Birchview Capital, LP G1 Therapeutics, Inc. Transaction History

Birchview Capital, LP

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 14, 2024	SELL	$2.1 - $4.83 $84,000 - $193,200	-40,000 Reduced 33.33%	80,000 $345,000
Q3 2023 Nov 14, 2023	BUY	$1.22 - $2.67 $97,600 - $213,600	80,000 Added 200.0%	120,000 $172,000
Q2 2019 Aug 06, 2019	BUY	$16.03 - $31.1 $400,750 - $777,500	25,000 Added 166.67%	40,000 $1.23 Million
Q3 2018 Nov 01, 2018	SELL	$43.15 - $67.97 $302,050 - $475,790	-7,000 Reduced 31.82%	15,000 $784,000
Q1 2018 May 07, 2018	BUY	$19.05 - $41.76 $419,100 - $918,720	22,000 New	22,000 $815,000

3.55M

11.7K

Ticker GTHX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 42,746,800
Market Cap $306M
Description
G1 Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the discovery, development, and commercialization of small molecule therapeutics for the treatment of patients with cancer. The company offers COSELA, which helps to decrease chemotherapy-induced myelosuppression in adult patients when administered prior to a platinum/...

Get notified when there are updates to the investment portfolio of Birchview Capital, LP, based on Form 13F filings with the SEC.

Stay updated on Birchview Capital, LP with notifications on news.